1. Home
  2. ENVB vs DSS Comparison

ENVB vs DSS Comparison

Compare ENVB & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

N/A

Current Price

$1.41

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Logo DSS Inc.

DSS

DSS Inc.

N/A

Current Price

$0.50

Market Cap

5.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
ENVB
DSS
Founded
1994
1984
Country
United States
United States
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
5.1M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
ENVB
DSS
Price
$1.41
$0.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 27.5K
26.8K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 42.45
EPS
★ N/A
N/A
Revenue
★ $39,914,675.00
$2,085,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$43.35
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.17
$0.36
52 Week High
$795.00
$1.86

Technical Indicators

Market Signals
Indicator
ENVB
DSS
Relative Strength Index (RSI) 44.66 50.80
Support Level $1.35 $0.49
Resistance Level $1.55 $0.57
Average True Range (ATR) 0.09 0.05
MACD -0.00 0.01
Stochastic Oscillator 22.73 60.66

Price Performance

Historical Comparison
ENVB
DSS

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

Share on Social Networks: